News Releases

NervGen Pharma Grants Stock Options

Vancouver, Canada. May 16, 2025 – NervGen Pharma Corp. (TSX-V: NGEN; OTCQB: NGENF), a clinical-stage biotechnology company dedicated to developing neuroreparative therapeutics, today announced that

Read More »